人参皂苷Rb1调节脑微血管NOS/NO改善脑细胞膜通透性

目的:探究人参皂苷Rb1在脂多糖(LPS)诱导的人脑微血管细胞模型中对脑细胞膜通透性的影响。方法:采用噻唑蓝比色法(MTT)及乳酸脱氢酶(LDH)释放检测不同浓度人参皂苷Rb1对LPS刺激人脑微血管内皮细胞系(HBMEC)存活率的影响;采用EVOM法检测HBMEC细胞通透性;采用Griess法、ELISA法及DAF-FM DA荧光探针分别检测NO、ONOO~-含量及eNOS、iNOS活性;Western blot法检测p-eNOS(ser1177)、iNOS蛋白的表达水平。结果:与正常对照组比较,LPS(5μg/m L)可明显降低HBMEC细胞存活率(P0.01);与LPS组比较,随着人参皂苷Rb1浓度的增加细胞存活率明显升高,且中、高剂量组(40、80μmol/L)具有显著性差异(P0.05、P0.01);LPS导致HBMEC单层细胞电阻值明显降低(P0.01),人参皂苷Rb1高剂量组(80μmol/L)可显著抑制LPS所致的细胞膜通透性升高(P0.05);LPS可明显降低HBMEC细胞NO含量(P0.01)升高ONOO~-含量(P0.05),人参皂苷Rb1中、高剂量组(40、80μmol/L)较LPS组具有显著升高NO含量,降低ONOO~-含量的作用(P0.05);与正常对照组比较,LPS组可明显降低HBMEC细胞磷酸化eNOS (ser1177)蛋白的表达水平,而显著升高iNOS蛋白表达水平(P0.01)。人参皂苷Rb1高剂量组(80μmol/L)较LPS组可显著升高p-eNOS(ser1177)蛋白的表达水平,降低iNOS蛋白的表达水平(P0.05)。结论:人参皂苷Rb1可有效降低iNOS活性,升高eNOS活性继而减少NO水平及ONOO~-含量,显著降低LPS导致的脑细胞膜通透性升高。     

20(S)-Ginsenoside Rh2 as aldose reductase inhibitor from Panax ginseng

The root of Panax ginseng C. A. Meyer (Araliaceae) is a well-known herbal medicine in East Asia. The major bioactive metabolites in this root are commonly identified as ginsenosides. A series of ginsenosides were determined for in vitro human recombinant aldose reductase. This Letter aims to clarify the structural requirement for aldose reductase inhibition. We discovered that only ginsenoside 20(S)-Rh2 showed potent against aldose reductase, with an IC₅₀ of 147.3 μM. These results implied that the stereochemistry of the hydroxyl group at C-20 may play an important role in aldose reductase inhibition. An understanding of these requirements is considered necessary in order to develop a new type of aldose reductase inhibitor. Furthermore, P. ginseng might be an important herbal medicine in preventing diabetic complications.     

三七地下部分皂甙成分的HPLC比较研究

应用HPLC定量分析方法,对三七(Panax notoginseng)地下部位的皂甙成分进行分析,通过比较人参皂甙Rg1,Rb1,Re,Rd和三七皂甙R1等5种主要皂甙成分和总皂甙的含量变化,探讨不同部位和组织中皂甙成分的分布规律。结果表明在三七药材的不同商品等级中,人参皂甙Rg1和Rb1的含量以主根60头为最高,5个主要皂甙的总含量也明显高于其他的等级;根茎的生物产量只为全根的18%,皂甙含量占25%以上;主根和根茎中韧皮部的生物产量和总皂甙的含量均高于木质部;二年生三七的生物产量及皂甙含量均较三年生三七低得多。不同表型三七的皂甙组成也有区别。     

老龄大鼠内侧隔核BDNF含量的变化及人参皂甙的保护作用

目的探讨老龄大鼠内侧隔核BDNF含量的变化情况及人参皂甙的保护作用,为人参皂甙的临床应用提供实验依据.方法选用Wistar大鼠40只,分成青年组(3个月)、老龄组(26个月)、给药组(自17个月始给予人参皂甙至26个月),采用免疫组织化学方法检测大鼠内侧隔核BDNF含量的变化情况.结果老龄组内侧隔核BDNF阳性反应物的平均灰度值与青年组相比显著增高(P<0.01),而给药组与老龄组相比其平均灰度值显著降低(P<0.01).结论老龄大鼠内侧隔核BDNF含量明显低于青年组,给药组BDNF含量较老龄组明显增加.说明人参皂甙具有保护BDNF,防止神经元退行性改变的作用.     

Ginsenoside Rd production from the major ginsenoside Rb<Subscript>1</Subscript> by <Emphasis Type="Italic">β</Emphasis>-glucosidase from <Emphasis Type="Italic">Thermus caldophilus</Emphasis>

Under optimum conditions (pH 5, 75°C, and 0.2 U purified enzyme ml⁻¹), 4 mg ginsenoside Rd was produced from 5 mg reagent-grade ginsenoside Rb₁ in 5 ml after 30 min by β-glucosidase from Thermus caldophilus GK24. Using a ginseng root extract containing 1 mg ginsenoside Rb₁ ml⁻¹ and 3.2 mg additional ginsenosides ml⁻¹, 1.23 mg ginsenoside Rd ml⁻¹ was produced after 18 h; the concentrations of ginsenosides Rb₁, Rb₂, and Rc used for ginsenoside Rd production were 0.77, 0.17, and 0.19 mg ml⁻¹, respectively.     

Three New Triterpenoid Saponins from Notoginseng Medicinal Fungal Substance

Three new triterpenoid saponins, named ginsenoside‐Rh₂₃ ( 1 ), ginsenoside‐Rh₂₄ ( 2 ), and ginsenoside‐Rh₂₅ ( 3 ), were isolated from notoginseng medicinal fungal substance. Their structures were elucidated by a combination of 1D‐ and 2D‐NMR, MS and chemical analysis. Compounds 1  –  3 exhibited moderate cytotoxic activity against MCF‐7 and NCI‐H460 cancer cell lines.     

人参皂甙 Rb1与Re对大鼠缺血再灌注心肌细胞凋亡的影响

目的观察人参皂甙Rb1与Re对缺血再灌注心肌细胞凋亡的影响,并比较两者的效应差异.方法结扎Wistar大鼠左冠状动脉前降支,建立大鼠缺血再灌注动物模型;采用透射电镜、缺口末端标记法检测心肌凋亡细胞,利用光学显微镜进行细胞计数.结果 (1)透射电镜发现缺血再灌注组缺血区出现心肌凋亡细胞,假手术组未发现心肌凋亡细胞;(2)缺血再灌注组心肌细胞凋亡数为134.45±45.61个/视野,人参皂甙Rb1治疗组51.65±13.71个/视野,人参皂甙Re治疗组90.66±19.22个/视野,三组间有非常显著性差异(P<0.01).结论心肌缺血再灌注诱导心肌细胞凋亡,人参皂甙Rb1和Re均可显著减少缺血再灌注心肌细胞的凋亡.证实人参皂甙Rb1与Re均有抑制缺血再灌注心肌细胞凋亡,减轻心肌缺血再灌注损伤的作用;人参皂甙Rb1的抗心肌细胞凋亡作用较Re的效果为佳.     

人参皂苷Rg1对抑郁症大鼠抑郁行为和海马神经元损伤、PKA、PKC的影响

摘要 目的：探讨与分析人参皂苷Rg1对抑郁症大鼠抑郁行为和海马神经元损伤、蛋白激酶A（PKA）与蛋白激酶C（PKC）的影响。方法：抑郁症大鼠48只随机平分为三组-模型组、实验1组、实验2组,每组16只大鼠。实验1组、实验2组每天2次灌胃给药（1 mg/mL、4 mg/mL人参皂苷Rg1）,给药体积为10 mL;模型组以相同方式按体重给予双蒸水。观察与记录鼠抑郁行为和海马神经元损伤、PKA、PKC表达变化情况。结果：实验1组、实验2组治疗第7 d、第14 d的逃避潜伏期都显著低于模型组,实验2组与实验1组相比也显著缩短（P<0.05）。实验1组、实验2组治疗第7 d、第14 d的糖水偏好率高于模型组,实验2组与实验1组相比也显著升高（P<0.05）。实验1组、实验2组治疗第7 d、第14 d的血清5-羟色胺较模型组高,血清皮质酮含量较模型组低,实验2组与实验1组对比也有明显差异（P<0.05）。实验1组、实验2组治疗第7 d、第14 d的海马神经元组织的PKA、PKC蛋白相对表达水平显著低于模型组,实验2组与实验1组相比也显著缩短（P<0.05）。结论：人参皂苷Rg1在抑郁症大鼠的应用能改善抑郁行为,增加糖水偏好率,降低逃避潜伏期,还可提高大鼠的血清5-羟色胺含量,降低血清皮质酮含量,降低海马神经元组织的PKA、PKC蛋白表达水平。     

Cell-mediated immunity: Correlation of mixed-leucocyte-macrophage migration inhibition with delayed-type hypersensitivity after immunization and donor-specific transfer of cell migration inhibition by dialyzable leucocyte extract

Active and adoptive sensitization of rhesus monkeys (Macacca mulatta) as well as the development of a novel sensitive in vitro cell migration inhibition assay for cell-mediated immunity (CMI) in this species are described. First, the correlation of mixed leucocyte-macrophage migration tests (LMMI) with the whole blood lymphocyte transformation (LT) and the delayed hypersensitivity skin test (DH) in immunized animals are shown. Second, these tests are used to demonstrate adoptive transfer of specific/nonspecific cellular immunity (CMI) with dialyzable leucocyte extract (DLE) from immunized donor to unimmunized recipient monkeys. Seventeen animals were immunized with keyhole limpet haemocyanin (KLH) or hepatitis B surface antigen (HBsAg) in Freund's complete adjuvant (FCA) or with FCA alone. Acquisition of antigen-specific cellmediated immunity was detected by all three tests within 5 weeks of immunization. Positive LMMI responses were associated with positive DH and LT. However, there was no correlation between the magnitude or time of development of the three responses. Therefore, the LMMI test, like the LT test, is an in vitro parameter of DH, but reflects the activity of different subpopulations of lymphocytes and is regulated by different mechanisms. In addition, 12 naive animals received DLE. Within 3 weeks, transfer of sensitivity was detected towards antigens to which the recipients had previously not been reactive but the donors had been. An enhancement of transformation response to phytohaemagglutinin was also seen. Thus, rhesus DLE contains both donor-specific transfer factor-like and nonspecific adjuvant-like activities. In DLE recipients, unlike immunized animals, LMMI responses were dissociated from DH or LT responses in that positive LMMI was mostly seen with negative DH or LT to antigens. Therefore, LMMI emerged as the most sensitive assay for detecting adoptive transfer of CMI by DLE in vivo, supporting the view that different mechanisms regulate LMMI, LT, and DH.     

Specific interaction of arabinose residue in ginsenoside with egg phosphatidylcholine vesicles

The interaction of the specific sugar residue in ginsenosides with egg phosphatidylcholine vesicles was investigated by ESR spectrometry using phosphatidic acid spin-labeled at the polar head groups. Ginsenoside-Rc, which has an α-l-arabinofuranose residue and agglutinability toward egg yolk phosphatidylcholine vesicles (Fukuda, K. et al. (1985) Biochim. Biophys. Acta 820, 199–206), caused the restriction of the segmental motion of spin-labeled phosphatidic acid in egg phosphatidylcholine vesicles, indicating that the saponin interacted with the polar head groups of vesicles. Other ginsenosides-Rb₂, Rb₁, Rd and p-nitrophenyl glycoside derivatives which have less or no agglutinability were also investigated in the same manner. Only ginsenoside-Rb₂ and p-nitrophenyl α-l-arabinofuranoside which have the specific sugar residue (arabinose) showed a strong interaction with the polar head groups of vesicles. To gain an insight into the mechanism of agglutination by ginsenoside-Rc, the interaction with the fatty acyl groups was also studied by using phosphatidylcholine spin-labeled at the fatty acyl groups. Ginsenoside-Rc increased the order parameter of the spin-labeled phosphatidylcholine, indicating that the saponin was inserted into lipid bilayers. In other saponins investigated, only ginsenoside-Rb₂ interacted with the fatty acyl part of vesicles. The process of expression of agglutination by ginsenoside-Rc was discussed on the basis of the ESR studies.